Valuation: EXACT Therapeutics

Market Cap 42.39M 4.42M 3.87M 3.6M 3.3M 6.18M 427M 6.32M 42.77M 16.75M 209M 16.59M 16.23M 720M P/E 2024
-2.49x
P/E 2025 -1x
Enterprise Value 18.47M 1.93M 1.69M 1.57M 1.44M 2.69M 186M 2.76M 18.64M 7.3M 91.12M 7.23M 7.07M 314M EV / Sales 2024
-
EV / Sales 2025 1,074,437,000x
Free-Float
30.97%
Yield 2024 *
-
Yield 2025 -
1 day+2.29%
1 week+0.75%
Current month-17.79%
1 month-12.99%
3 months-57.86%
6 months-66.33%
Current year-51.45%
1 week 0.64
Extreme 0.635
0.73
1 month 0.64
Extreme 0.635
0.88
Current year 0.58
Extreme 0.58
2.7
1 year 0.58
Extreme 0.58
3
3 years 0.58
Extreme 0.58
20
5 years 0.58
Extreme 0.58
24
10 years 0.58
Extreme 0.58
53.59
Manager TitleAgeSince
Chief Executive Officer 66 2022-06-05
Chief Operating Officer - 2011-12-31
Director of Finance/CFO - 2022-09-30
Director TitleAgeSince
Chairman 55 2018-06-21
Chairman - 2022-06-07
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
1/4/23 Buy

Founder

2,500 0.0083%
1/4/23 Buy

Chief Technology Officer

2,500 0.0083%
1/4/23 Buy

Chairman

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%+0.75%-77.67%-94.17% 4.3M
-4.89%-7.90%-4.49%+9.27% 48.5B
-0.14%-1.05%+376.39%+583.71% 38.97B
+0.39%+4.36%+9.59%+61.99% 35.43B
-1.54%-4.48%+24.89%-13.03% 33.65B
-0.87%-1.56%-1.43%+29.16% 26.58B
-1.28%-5.14% - - 16.82B
-0.67%-1.50%+70.98%+115.31% 15.18B
+1.32%+2.29%+14.62%+15.52% 13.89B
+0.40%-0.41%+19.80%-31.98% 12.76B
Average -0.50%-1.24%+48.08%+75.09% 24.18B
Weighted average by Cap. -1.29%-1.28%+76.11%+121.29%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.29 0.02 0.02 1
Net income -52.33M -5.46M -4.78M -4.44M -4.08M -7.63M -527M -7.8M -52.81M -20.68M -258M -20.48M -20.04M -889M -86.97M -9.07M -7.95M -7.38M -6.78M -12.68M -875M -12.97M -87.76M -34.36M -429M -34.04M -33.3M -1.48B
Net Debt -98.89M -10.31M -9.04M -8.39M -7.71M -14.42M -996M -14.75M -99.79M -39.07M -488M -38.7M -37.87M -1.68B -23.91M -2.49M -2.18M -2.03M -1.86M -3.49M -241M -3.57M -24.13M -9.45M -118M -9.36M -9.16M -406M
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
26-07-22 NOK 0.6700 +2.29% 33,153
26-07-21 NOK 0.6550 -10.27% 107,842
26-07-20 NOK 0.7300 +0.69% 1,116
26-07-17 NOK 0.7250 0.00% 0
26-07-16 NOK 0.7250 0.00% 584
  1. Stock Market
  2. Stocks
  3. EXTX Stock